All about synergies: Experts weigh in on the Weston family’s acquisition of Boots

Canada’s Weston family is adding a major retailer to its portfolio: U.K. pharmacy chain Boots. The family, whose retail empire in Canada includes Loblaw and Shoppers Drug Mart (Pharmaprix in Quebec), will make the US$8.9 billion acquisition through its holding company, Wittington Investments. The deal includes Boots’ retail operations in the U.K., Ireland and Thailand, its franchised operations, optical division and No7 Beauty Co. 

Toronto-based Fairfax Financial Holdings will contribute up to US$2.3 billion toward the purchase in exchange for a 50% stake in Boots, while Wittington will retain operational control. The transaction is expected to close in the first quarter of 2027, with Galen Weston set to become Boots’ chairman.  

Canadian Grocer asked retail experts to weigh in on the acquisition, what it might mean for Shoppers Drug Mart and the burning question: Could Boots expand into Canada? Here’s what they said. 

Amar Singh, senior director, Kantar Consulting:  We feel it’s a very strong deal, and there are a lot of synergies for both markets to learn from each other.

We already see Boots’ private-label brands, No7 and Soap & Glory, within Shoppers Drug Mart, so there has been a relationship there. The Weston family is not new to owning stores in the U.K., so they understand the market. 

I think it’s a learning opportunity for Shoppers Drug Mart to inform its private-label innovation more than anything else. That’s one of the clearest wins: I think we’re going to see more of the No7 innovation coming into Shoppers Drug Mart. Boots works with the University of Manchester on product innovation for No7, so they have a strong partnership there. We can expect to see some of those ideas percolating into Life Brand [Shoppers’ private-label brand]. And if not, you’re going to see more No7 and Soap & Glory products at Shoppers Drug Mart. 

Boots is also expanding its healthcare and clinical care services. Canada and the U.K. both have public healthcare systems, so there’s a lot of overlap in how medical care is delivered in both markets. So, I think they can also exchange information in that respect and have more informed strategies to target and engage patients. 

READ: Loblaw launches AI-powered health chat tool

Where Shoppers Drug Mart can get a lot of inspiration is in merchandising. Boots merchandising is so clean, the stores are well organized, and the aisles and shelves are easy to navigate. I think we’re going to see a lot of that coming into Canada as well. So, operations and private label are the biggest wins. 

I don’t think [opening Boots stores here] is going to happen. Shoppers Drug Mart is a very well-known brand in Canada. It has great recognition. With Boots, we could see a store-within-a-store concept emerge. But I don’t know if that would be successful. There’s a ton of equity in Canada for Boots—it used to have stores here many decades ago. But I think their private-label portfolio will be more pronounced in Canada than ever before. Introducing the banner probably would not be a priority for Loblaw because they have such a strong brand with Shoppers Drug Mart. I don’t think they would want to tinker around with that too much.

David Soberman, marketing professor, University of Toronto’s Rotman School of Management: I’m not sure bringing Boots to Canada is what they would do. They’ve spent a lot of money building up the Shoppers Drug Mart brand in Canada and Pharmaprix in Quebec, so I would not see that as being a possibility. But Boots has a lot of well-known and successful products that we may start to see in Shoppers Drug Mart and vice versa. Life Brand probably has items that could be used to strengthen Boots’ offering in the U.K. So, I think there could be a lot of cross-pollination going both ways. 

Additionally, the Brits love their confectionery. I always found their confectionery sections a lot more appealing than what I’ve seen at Shoppers Drug Mart. So, there could be some good synergies there as each organization sees what’s appealing and special in their organizations, and then adopt those. There’s a big opportunity here for two-way learning. 

Beyond that, the purchasing department for Shoppers Drug Mart/Boots is going to have a lot more heft when dealing with the manufacturers that produce their private-label products. When you have certain products made by a contract manufacturer, you’re able to increase the volumes you are asking for. You may have to change the labels—we require bilingual packaging and they don’t, for example—but ordering 400,000 units is a lot different than ordering 200,000 units. 

I think Canadians should feel quite proud of this [acquisition]. We have a Canadian company that is, in some ways, almost becoming a global powerhouse. And we don’t have many of them. This is a good sign.

Bruce Winder, retail analyst, Bruce Winder Retail: When I heard about the deal, I thought it made sense for a few reasons. Boots has been passed around a bit in recent years by different private equity owners. Most recently, Sycamore Partners owned it. They bought it last year as part of the Walgreens deal, and I think they were trying to unload it.

I think it’s a brand that needs a bit of investment, some TLC and some direction. What I like about Wittington Investments’ acquisition, alongside Fairfax, is that the Westons have a lot of experience managing Shoppers Drug Mart in Canada and they can bring that knowledge to Boots to help improve the business over the long term. So, it seems to make sense on the surface. Whittington has experience in the U.K. as well. They’re part owners of the holding company that owns Primark, a large clothing retailer, and they previously owned Selfridges department store.

As for whether Boots could expand into Canada, I don’t know if it needs to. Shoppers Drug Mart is already dominant in Canada, along with Pharmaprix in Quebec. So, it wouldn't seem to make sense on the surface to bring Boots here. It feels a bit too similar to Shoppers Drug Mart. They’ve already got some nice sales momentum with Shoppers Drug Mart in Canada and the pharmacies through Loblaw. They’ve also got great plans for expansion and healthcare services. Anything can happen, but it feels like a Canadian expansion wouldn’t be on the radar. 

It’s more about allocating resources toward bringing some of the best practices at Shoppers Drug Mart to Boots—enhancing the loyalty program, healthcare services and beauty. They can also leverage synergies in supplier relationships, marketing and product development.